http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Fortrea Reports Fourth Quarter and Full-Year 2024 Results; Issues Full-Year 2025 Guidance
-
Fortrea (FTRE) appoints Erin Russell to Board
-
Fortrea to Add Erin L. Russell to Board of Directors
-
Society for Clinical Research Sites (SCRS) and Fortrea Partner to Advance Collaboration in Clinical Research
-
Fortrea Announces Date for Fourth Quarter and Full Year 2024 Financial Results and Conference Call
-
Fortrea to Present at the Evercore HealthCONx Conference
-
Fortrea to Present at the Citi Global Healthcare Conference
-
Fortrea Reports Third Quarter 2024 Results
-
Fortrea Releases Inaugural Corporate Social Responsibility Report
-
Fortrea Announces Date for Third Quarter 2024 Financial Results and Conference Call
-
Fortrea Reports Second Quarter 2024 Results
-
Fortrea Announces Date for Second Quarter 2024 Financial Results and Conference Call
-
Fortrea (FTRE) Appoints Robert Parks as Chief Accounting Officer
-
Fortrea Appoints Robert Parks as Chief Accounting Officer
-
Fortrea (FTRE) Launches AI Innovation Studio
-
Fortrea Launches AI Innovation Studio to Galvanize Technology and Human Solutions to Improve Clinical Trial Delivery
-
Fortrea to Participate in Virtual Fireside Chat with Evercore ISI
-
Fortrea Completes Divestiture of Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
-
Fortrea to Present at the Jefferies Global Healthcare Conference
-
Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research
-
Fortrea (FTRE) Appoints Machelle Sanders to its Board
-
Fortrea Appoints Machelle Sanders to Board of Directors
-
Fortrea Reports First Quarter 2024 Results
-
Fortrea Reschedules Release of First Quarter 2024 Financial Results and Conference Call
-
Fortrea Announces Date for First Quarter 2024 Financial Results and Conference Call
-
Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
-
Fortrea Reports Fourth Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance
-
Fortrea Increases Patient Access Capabilities and Cold Chain Expertise with FortreaRx™ Expansion
-
Fortrea Increases Patient Access Capabilities and Cold Chain Expertise with FortreaRx™ Expansion
-
Fortrea to Present at the Barclays 26th Annual Global Healthcare Conference
-
Fortrea Announces Date for Fourth Quarter and Full Year 2023 Financial Results and Conference Call
-
Fortrea Establishes Industry Partnership with Veeva and Advarra to Streamline Patient and Site Clinical Trial Experience
-
Fortrea Previews J.P. Morgan Healthcare Conference Updates
-
FORTREA SELECTS COGNIZANT AS ITS TECHNOLOGY TRANSFORMATION PROVIDER
-
Fortrea to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Fortrea Convenes New Site Advisory Board
-
Fortrea (FTRE) Announces AI-Driven Partnership with Medidata to Increase Diversity in Clinical Trials
-
Fortrea Announces AI-Driven Partnership with Medidata to Increase Diversity in Clinical Trials
-
Fortrea Reports Third Quarter 2023 Results
-
Fortrea Completes Expansion of Clinical Pharmacology Solutions Following Targeted Investments at its Four Clinical Research Units in U.S. and U.K.
-
Fortrea Appoints Life Science Executive Dr. John Doyle to Lead Consulting Team
-
Fortrea Announces Date for Third Quarter 2023 Financial Results and Conference Call
-
Fortrea’s Jim Cameli Named a Top 100 Global Chief Information Security Officer by HotTopics
-
Fortrea to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
-
Fortrea to Present at the Baird 2023 Global Healthcare Conference
-
Fortrea Reports Second Quarter 2023 Results and Provides Full-Year 2023 Guidance
-
Fortrea Announces Date for Second Quarter 2023 Financial Results and Conference Call
-
Fortrea Launches as Leading, Global Contract Research Organization Positioned to Bring Life-Changing Therapies to Patients Faster
-
Labcorp (LH) completed the spin-off of Fortrea (FTRE)

